Faes Farma

Faes Farma Net Margin

The Net Profit Margin of Faes Farma (FAE.MC) as of Sep 30, 2026 is 13.04 %. In the previous year, Net Profit Margin was 22.56 % — a change of -42.18% (lower).

Net Margin

13.04 %

YoY

-42.18%

Last updated:

Net Profit Margin of Faes Farma is 2026 13.04 % . Net Profit Margin of Faes Farma was 2025 22.56 % . It decreases by -42.18% lower compared to the previous year.

For Faes Farma, the net margin of 13.0% is down versus 20.7% a few years ago.

The Faes Farma Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
15.91 EUR
Jan 1, 2019
17.90 EUR
Jan 1, 2020
19.08 EUR
Jan 1, 2021
20.67 EUR
Jan 1, 2022
20.40 EUR
Jan 1, 2023
20.37 EUR
Jan 1, 2024
22.56 EUR
Jan 1, 2025
13.04 EUR
The Faes Farma Net Margin history
YEARNet MarginYoY
13.04 %-42.18%
22.56 %+10.75%
20.37 %-0.14%
20.40 %-1.33%
20.67 %+8.35%
19.08 %+6.61%
17.90 %+12.50%
15.91 %+3.46%
15.38 %-3.92%
16.00 %+7.92%
14.83 %+12.24%
13.21 %+10,443.97%
0.13 %+13.07%
0.11 %+48.67%
0.07 %-24.52%
0.10 %-28.53%
0.14 %+36.82%
0.10 %-15.20%
0.12 %-3.13%
0.12 %—
Access this data via the Eulerpool API
Get Free API Key

Faes Farma Stock analysis

What does Faes Farma do? The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market. Faes Farma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Faes Farma stock

Net Profit Margin of Faes Farma is 13.04 % in 2026.

Net Profit Margin of Faes Farma changed from 22.56 % to 13.04 %, representing a -42.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Faes Farma since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Faes Farma with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — Faes Farma

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Faes Farma